Annual ROE
-118.94%
-78.15%-191.59%
31 December 2023
Summary:
AIM ImmunoTech annual return on equity is currently -118.94%, with the most recent change of -78.15% (-191.59%) on 31 December 2023. During the last 3 years, it has fallen by -80.40% (-208.61%). AIM annual ROE is now -481.90% below its all-time high of -20.44%, reached on 31 December 2009.AIM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-256.33%
-66.58%-35.09%
30 September 2024
Summary:
AIM ImmunoTech quarterly return on equity is currently -256.33%, with the most recent change of -66.58% (-35.09%) on 30 September 2024. Over the past year, it has dropped by -194.83% (-316.80%). AIM quarterly ROE is now -1982.29% below its all-time high of -12.31%, reached on 30 June 2010.AIM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -191.6% | -316.8% |
3 y3 years | -208.6% | -855.7% |
5 y5 years | +16.0% | -84.8% |
AIM ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -267.4% | at low | -855.7% | at low |
5 y | 5 years | -267.4% | +16.0% | -895.5% | at low |
alltime | all time | -481.9% | +41.3% | -1982.3% | +2.0% |
AIM ImmunoTech ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -256.33%(+35.1%) |
June 2024 | - | -189.75%(+25.4%) |
Mar 2024 | - | -151.37%(+42.6%) |
Dec 2023 | -118.94%(+191.6%) | -106.14%(+72.6%) |
Sept 2023 | - | -61.50%(+24.0%) |
June 2023 | - | -49.58%(+12.2%) |
Mar 2023 | - | -44.19%(+9.1%) |
Dec 2022 | -40.79%(+26.0%) | -40.49%(+2.2%) |
Sept 2022 | - | -39.63%(+23.8%) |
June 2022 | - | -32.01%(+2.0%) |
Mar 2022 | - | -31.37%(+3.9%) |
Dec 2021 | -32.37%(-16.0%) | -30.20%(+12.6%) |
Sept 2021 | - | -26.82%(-1.7%) |
June 2021 | - | -27.29%(+6.0%) |
Mar 2021 | - | -25.75%(-22.2%) |
Dec 2020 | -38.54%(-61.9%) | -33.08%(-2.3%) |
Sept 2020 | - | -33.86%(-29.8%) |
June 2020 | - | -48.25%(-28.6%) |
Mar 2020 | - | -67.62%(-38.3%) |
Dec 2019 | -101.03%(-28.7%) | -109.60%(-21.0%) |
Sept 2019 | - | -138.72%(-14.3%) |
June 2019 | - | -161.93%(+7.7%) |
Mar 2019 | - | -150.39%(+21.2%) |
Dec 2018 | -141.63%(+107.5%) | -124.04%(+8.2%) |
Sept 2018 | - | -114.65%(+32.5%) |
June 2018 | - | -86.55%(+10.9%) |
Mar 2018 | - | -78.04%(+8.7%) |
Dec 2017 | -68.25%(+63.2%) | -71.79%(+26.3%) |
Sept 2017 | - | -56.83%(-8.4%) |
June 2017 | - | -62.07%(+23.2%) |
Mar 2017 | - | -50.38%(+18.7%) |
Dec 2016 | -41.83%(-37.7%) | -42.43%(-13.9%) |
Sept 2016 | - | -49.27%(+0.6%) |
June 2016 | - | -49.00%(-18.7%) |
Mar 2016 | - | -60.29%(-3.2%) |
Dec 2015 | -67.13%(+4.4%) | -62.28%(-3.5%) |
Sept 2015 | - | -64.51%(+2.4%) |
June 2015 | - | -63.02%(+3.2%) |
Mar 2015 | - | -61.06%(-0.6%) |
Dec 2014 | -64.27%(+46.6%) | -61.43%(+13.2%) |
Sept 2014 | - | -54.26%(+0.7%) |
June 2014 | - | -53.86%(+12.0%) |
Mar 2014 | - | -48.11%(+8.9%) |
Dec 2013 | -43.85%(+4.4%) | -44.17%(-8.7%) |
Sept 2013 | - | -48.40%(-6.6%) |
June 2013 | - | -51.83%(+6.9%) |
Mar 2013 | - | -48.49%(+5.6%) |
Dec 2012 | -41.99%(+95.4%) | -45.92%(+13.1%) |
Sept 2012 | - | -40.61%(+39.6%) |
June 2012 | - | -29.09%(+13.7%) |
Mar 2012 | - | -25.59%(+21.6%) |
Dec 2011 | -21.49%(-14.4%) | -21.05%(+15.0%) |
Sept 2011 | - | -18.30%(-5.8%) |
June 2011 | - | -19.42%(+16.8%) |
Mar 2011 | - | -16.62%(-31.2%) |
Dec 2010 | -25.11% | -24.14%(+67.6%) |
Sept 2010 | - | -14.40%(+17.0%) |
June 2010 | - | -12.31%(-37.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | -19.80%(+6.1%) |
Dec 2009 | -20.44%(-72.8%) | -18.66%(-55.3%) |
Sept 2009 | - | -41.74%(-39.5%) |
June 2009 | - | -68.98%(-22.7%) |
Mar 2009 | - | -89.28%(+15.5%) |
Dec 2008 | -75.20%(-5.3%) | -77.33%(+9.8%) |
Sept 2008 | - | -70.40%(-2.3%) |
June 2008 | - | -72.03%(+3.6%) |
Mar 2008 | - | -69.51%(-5.6%) |
Dec 2007 | -79.37%(-11.3%) | -73.65%(-5.8%) |
Sept 2007 | - | -78.17%(+11.5%) |
June 2007 | - | -70.12%(-5.9%) |
Mar 2007 | - | -74.50%(-11.0%) |
Dec 2006 | -89.44%(+44.4%) | -83.69%(-4.0%) |
Sept 2006 | - | -87.18%(-0.1%) |
June 2006 | - | -87.24%(+3.8%) |
Mar 2006 | - | -84.04%(+16.0%) |
Dec 2005 | -61.94%(-43.5%) | -72.42%(+168.7%) |
Sept 2005 | - | -26.95%(-47.2%) |
June 2005 | - | -51.01%(-26.8%) |
Mar 2005 | - | -69.66%(-36.6%) |
Dec 2004 | -109.63%(-45.8%) | -109.87%(-43.3%) |
Sept 2004 | - | -193.68%(-17.2%) |
June 2004 | - | -233.95%(-10.5%) |
Mar 2004 | - | -261.50%(+28.3%) |
Dec 2003 | -202.45%(+109.1%) | -203.83%(+4.1%) |
Sept 2003 | - | -195.75%(+42.5%) |
June 2003 | - | -137.33%(+17.0%) |
Mar 2003 | - | -117.42%(+21.2%) |
Dec 2002 | -96.80%(+19.0%) | -96.87%(-3.2%) |
Sept 2002 | - | -100.08%(+2.4%) |
June 2002 | - | -97.73%(+7.6%) |
Mar 2002 | - | -90.83%(-6.5%) |
Dec 2001 | -81.33%(+15.4%) | -97.14%(+0.3%) |
Sept 2001 | - | -96.88%(+15.7%) |
June 2001 | - | -83.73%(+15.5%) |
Mar 2001 | - | -72.51%(+11.6%) |
Dec 2000 | -70.47%(-20.1%) | -64.96%(-25.9%) |
Sept 2000 | - | -87.71%(-2.4%) |
June 2000 | - | -89.86%(-7.6%) |
Mar 2000 | - | -97.23%(-7.0%) |
Dec 1999 | -88.16%(+56.4%) | -104.54%(+32.4%) |
Sept 1999 | - | -78.95%(+0.6%) |
June 1999 | - | -78.48%(+10.1%) |
Mar 1999 | - | -71.31%(+16.3%) |
Dec 1998 | -56.37%(-23.3%) | -61.34%(-5.1%) |
Sept 1998 | - | -64.66%(-24.4%) |
June 1998 | - | -85.55%(-1.5%) |
Mar 1998 | - | -86.89%(-23.1%) |
Dec 1997 | -73.49%(-17.7%) | -112.96%(-14.4%) |
Sept 1997 | - | -131.91%(+1.3%) |
June 1997 | - | -130.25%(+0.4%) |
Mar 1997 | - | -129.71%(+33.1%) |
Dec 1996 | -89.32%(+118.3%) | -97.46%(+19.8%) |
Sept 1996 | - | -81.36%(+9.5%) |
June 1996 | - | -74.29%(+50.4%) |
Mar 1996 | - | -49.38%(+20.7%) |
Dec 1995 | -40.91% | -40.91% |
FAQ
- What is AIM ImmunoTech annual return on equity?
- What is the all time high annual ROE for AIM ImmunoTech?
- What is AIM ImmunoTech annual ROE year-on-year change?
- What is AIM ImmunoTech quarterly return on equity?
- What is the all time high quarterly ROE for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly ROE year-on-year change?
What is AIM ImmunoTech annual return on equity?
The current annual ROE of AIM is -118.94%
What is the all time high annual ROE for AIM ImmunoTech?
AIM ImmunoTech all-time high annual return on equity is -20.44%
What is AIM ImmunoTech annual ROE year-on-year change?
Over the past year, AIM annual return on equity has changed by -78.15% (-191.59%)
What is AIM ImmunoTech quarterly return on equity?
The current quarterly ROE of AIM is -256.33%
What is the all time high quarterly ROE for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly return on equity is -12.31%
What is AIM ImmunoTech quarterly ROE year-on-year change?
Over the past year, AIM quarterly return on equity has changed by -194.83% (-316.80%)